Karydakis Versus Limberg Flap for the Management of Primary Sacrococcygeal Pilonidal Sinus

November 26, 2025 updated by: Tamer.A.A.M.Habeeb, Zagazig University

Outcomes of Karydakis Versus Limberg Flap for the Management of Primary Sacrococcygeal Pilonidal Sinus

study comparing the Karydakis and Limberg flaps

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

study comparing the Karydakis and Limberg flaps in management of pilonidal sinus

Study Type

Observational

Enrollment (Actual)

352

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Sharqia Province
      • Zagazig, Sharqia Province, Egypt, 1234
        • Zagazig University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

all patients > 18 years with PNS underwent karydakis and limberg flap

Description

Inclusion Criteria:

  • sexually active,
  • employed or driving ,
  • patients diagnosed with sacrococcygeal primary symptomatic pilonidal sinus based on clinical aspects, physical examination, and disease-specific history

Exclusion Criteria:

  • lost follow up
  • refuse surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Karadakis flap
Karadakis flap for managing pilonidal cyst
Procedure: karydakis surgery
karydakis surgery for managing pilonidal sinus
Limberg flap
Procedure: Limberg flap
using rheumboid flap to cover the defect after pilonidal sinus excision

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sexual function comparison
Time Frame: 1 year
sexual function evaluation through questionnaire modulated by our group and asked to the patients
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
driving function evaluation
Time Frame: 1 year
driving evaluation after surgery through questionnaire modulated by our group and asked to the patients
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Zagazig University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Actual)

July 1, 2024

Study Completion (Actual)

July 1, 2024

Study Registration Dates

First Submitted

November 13, 2025

First Submitted That Met QC Criteria

November 26, 2025

First Posted (Estimated)

December 9, 2025

Study Record Updates

Last Update Posted (Estimated)

December 9, 2025

Last Update Submitted That Met QC Criteria

November 26, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • pilonidal sinus

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

upon reasonable requirement

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe